Roivant Sciences Ltd.

Roivant Sciences Ltd.

Roivant Sciences Ltd.

Overview
Date Founded

2014

Headquarters

Clarendon House,2 Church Street,Hamilton HM 11

Type of Company

Private

Industries

Biotechnology
Hospitals & Patient Services
Holding Companies

Company Description

Roivant Sciences Ltd. functions as a holding company whose subsidiaries operates as biopharmaceutical company which engages in development and commercialization of novel therapies in therapeutic area. The company is headquartered in Hamilton, Bermuda.

Executives & Employees

Founder

Chief Investment Officer & President

Chief Financial Officer

Chief Operating Officer

Chief Medical Officer

Chief Accounting Officer

Chief Executive Officer, Altavant

Head, Global Transactions & Risk Management

Head of Global Transactions

Chief of Research & Development

Board of Directors

Founder at AlphaSimplex Group LLC

Former Chief Financial Officer at CareDx, Inc.

Former Governor of Kansas

Former Senior Executive Vice President & Chief Administrative Officer at Rite Aid Corp.

Former Chief Financial Officer at Ocular Therapeutix, Inc.

Co-Founder at Medivation, Inc.

Executive Vice President & Chief Financial Officer at Quest Diagnostics, Inc.

Chief Executive Officer at Pharvaris BV

President & Chief Executive Officer at Verity BioConsulting LLC

Former President & Chief Executive Officer at Agensys, Inc.

Paths to Roivant Sciences Ltd.
Potential Connections via
Relationship Science
You
Roivant Sciences Ltd.
Transaction Clients

Advised on issued . USD Common Shares

Advisors & Consultants
Advisor

Founder at Nuvation Bio, Inc.

Clients

Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. The company's product includes relugolix, which is an oral, once-daily and small molecule that acts as a GnRH receptor antagonist. It also develops MVT-602 a kisspeptin agonist for the treatment of female infertility. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.

Axovant Gene Therapies Ltd. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. The company was founded on October 31, 2014 and is headquartered in London, United Kingdom.

Suppliers
Portola Pharmaceuticals, Inc. Pension Funds & Sovereign Wealth | South San Francisco, CA

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

ArQule, Inc. Pharmaceuticals | Woburn, MA

ArQule, Inc. is a biopharmaceutical company. It engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.

Nabriva Therapeutics Plc Pharmaceuticals | Dublin, Ireland

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Roivant Sciences Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Roivant Sciences Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Roivant Sciences Ltd..